Daniel Brennan was appointed to Nuance’s Board of Directors on September 12, 2018. Mr. Brennan is the Executive Vice President and Chief Financial Officer of Boston Scientific, a manufacturer of medical devices, where he has worked since 1996. Prior to his current position, Dan served the firm in roles of increasing importance including corporate controller, vice president of finance for worldwide financial and strategic planning, investor relations, international finance and controller of several businesses. He is a certified public account and holds a Bachelor of Science degree in Finance and Investments and a Master of Business Administration from Babson College. Mr. Brennan serves as a member of Nuance’s Audit Committee.